Background: Standard therapy for postoperative pain after laparoscopic colorectal surgeries at the Tan Tock Seng Hospital consists of intravenous morphine via patient-controlled analgesia (PCA) for the first 24–48 h, followed by oral analgesics. We compared the efficacy and safety of oral controlled-release (CR) oxycodone hydrochloride (OxyContin® tablets) and PCA after laparoscopic colorectal surgeries. Methods: Between March and August 2006 (phase 1 study), 14 patients underwent laparoscopic colectomy, laparoscopic hemicolectomy or laparoscopic-assisted anterior resections. All patients were on oral CR oxycodone with oral immediate-release oxycodone on an as-needed basis for breakthrough pain. Pain intensity, analgesic use, length of hospital stay and side effects were evaluated. These were compared to data obtained from a second study of a similar design where 9 patients underwent similar operations from October 2006 to July 2007 (phase 2 study) and were on PCA morphine. Results: All patients in the CR oxycodone and PCA morphine groups needed the opioid medication for only 2 days. There was no difference in mean (range) postoperative pain intensity scores between patients on oxycodone and those on PCA morphine for the 1st postoperative day [2.07 (0–5) vs. 2.78 (2–4) on a Visual Analogue Scale (VAS) from 0 to 10; p = 0.10] and the 2nd postoperative day [1.14 (0–2) vs. 1.67 (0–3); p = 0.10]. Generalized estimating equations with linear link function confirmed that there was a significant relief of pain in patients after operation. On average, the VAS score of pain was 1.00 units lower on day 2 when compared with day 1 (p < 0.01). The mean (range) doses of oxycodone used on the 1st and 2nd postoperative day were 13.57 mg (10–30) and 15.36 mg (10–30), and the mean (range) doses of morphine used on the 1st and 2nd postoperative day were 14.9 mg (8–28) and 16.3 mg (4–31), respectively. Incidence of nausea and vomiting was 14.2 and 20% for the CR oxycodone and PCA groups, respectively. Conclusions: Oral CR oxycodone 20 mg per day is a cheaper, convenient and an efficacious alternative analgesic to PCA opioids after laparoscopic colorectal surgery.

Keywords:
Controlled-release oxycodone, Patient-controlled analgesia, Postoperative pain, Laparoscopic colectomy
1.
Apfelbaum JL, Chan C, Mehta SS, Gan TJ: Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003;97:534–540.
2.
Sinatra RS, Torres J, Bustos AM: Pain management after major orthopaedic surgery: current strategies and new concepts. J Am Acad Orthop Surg 2002;10:117–129.
3.
American Society of Anesthesiologists Task Force on Acute Pain Management: Practice guidelines for acute pain management in the postoperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004;100:1573–1581.
4.
Strassels SA, Chen C, Carr DB: Postoperative analgesia: economics, resource use, and patient satisfaction in an urban teaching hospital. Anaesth Analg 2002;94:130–137.
5.
Acute Pain Management Guideline Panel: Acute Pain Management: Operative or Medical Procedures and Trauma. Clinical Practice Guideline. Rockville, Agency for Health Care Policy and Research, US Department of Health and Human Services, Public Health Service, 1992, AHCPR Publication No 92-0032.
6.
Steele SR, Brown TA, Rush RM, Martin MJ: Laparoscopic vs open colectomy for colon cancer: results from a large nationwide population-based analysis. J Gastrointest Surg 2008;12:583–591.
7.
Kaiko RF, Benziger DP, Fitzmarin RD, Burke BE, Reder RF, Goldenheim PD: Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther 1996;59:52–61.
8.
Patt RB: Using controlled-release oxycodone for the management of chronic cancer and noncancer pain. Am Pain Soc Bull 1996;6:1–6.
9.
Sunshine A, Olson NZ, Colon A, Rivera J, Kaiko RF, Fitzmartin RD, et al: Analgesic efficacy of controlled-release oxycodone in postoperative pain. J Clin Pharmacol 1996;36:595–603.
10.
Ginsberg B, Sinatra RS, Adler LJ, Crews JC, Hord AH, Laurito CE, Ashburn MA: Conversion to oral controlled-release oxycodone from intravenous opioid analgesic in the postoperative setting. Pain Med 2003;4:31–38.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.